To highlight the condition and support its timely diagnosis, Boehringer Ingelheim Vetmedica has joined forces with three equine groups to launch the “Talk About Cushing’s (TAC)” campaign.

To highlight the condition and support its timely diagnosis, Boehringer Ingelheim Vetmedica has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the “Talk About Cushing’s (TAC)” campaign. 

The initiative, which will take place throughout September and October 2011, is aimed at raising awareness of Cushing’s Disease and its clinical signs, perhaps the most familiar of which is hirsutism (abnormal hair growth, or delayed shedding). 

Talk About Cushing'sHorse owners can download a £15 money-off voucher from throughout the TAC initiative, which can be redeemed through their veterinary practice against blood test costs.

Craig Beck, vet and equine sales and marketing manager at Boehringer Ingelheim Vetmedica, said: “More than 80% of horses suffering from laminitis may have an underlying endocrine disorder, such as Cushing’s Disease. The TAC campaign will raise awareness of Cushing’s Disease amongst both veterinary professionals and owners. It should make it easier for vets to go ahead with endocrine testing in horses and ponies with recurrent laminitis, diagnosing and treating earlier in the course of the disease.”

Lee Hackett, head of welfare at the British Horse Society, added: “Cushing’s Disease is relatively common in horses yet in our experience it frequently goes undiagnosed and untreated. This is why we are fully behind the “Talk About Cushing’s” campaign – anything that raises awareness and understanding of this disease has to be of benefit to equine welfare.”

Backed by hard-hitting marketing activity, including an extensive advertising and PR campaign in equine consumer media, Boehringer Ingelheim Vetmedica has produced a marketing pack for veterinary practices to utilise in the run up and during TAC. This includes leaflets, invoice stickers, a veterinary practice toolkit featuring an owner evening presentation, editorial copy for newsletters and websites and images to support the campaign.


  • For further information on TAC or Prascend, the first licensed product for the treatment of Cushing’s Disease, visit, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.


View your activity >

Leave a Reply

Be the First to Comment!

Notify of